Fri, 25 Apr, 2014

INVESTMENT NEWS

Market Buzz-
Company Search

Search QCK.COM


Thu, 24 Apr, 2014
Barring any unexpected events global capital markets will have little to chew on come Friday.
Thu, 24 Apr, 2014
A round-up of the biggest director deals today so far.
Thu, 24 Apr, 2014
Global M&A activity gave stocks in the healthcare equipment and services a boost on Thursday, with Smith & Nephew rising strongly after a takeover bid for sector peer Biomet.
Thu, 24 Apr, 2014
Panmure Gordon has kept a 'hold' recommendation for AstraZeneca after a mixed first quarter from the pharmaceutical group, but said there were some 'bright lights' in the results such as its heartburn treatment Nexium.
Thu, 24 Apr, 2014
Despite reporting an decent first-quarter statement, retail-focused property group Hammerson received a ratings downgrade by HSBC on Thursday from 'overweight' to 'neutral' on the back of the stock's recent strong run.
Thu, 24 Apr, 2014
Berenberg has reiterated its 'sell' recommendation for pay-TV and broadband group British Sky Broadcasting (BSkyB), saying that the company's upcoming third-quarter statement will probably show signs of market share loss.
Thu, 24 Apr, 2014
Ahead of Barclays' AGM, this afternoon, analyst Ian Gordon at Investec writes that: "As a generality, we regard the Barclays AGM as a circus which can be safely ignored." However, they quickly add that today's first quarter trading update was more detailed than expected and "appears to be a shade ahead of our expectations."
Thu, 24 Apr, 2014
Panmure Gordon has kept a 'hold' recommendation for AstraZeneca after a mixed first quarter from the pharmaceutical group, but said there were some 'bright lights' in the results such as its heartburn treatment Nexium.
Thu, 24 Apr, 2014
Broker Investec retained its 'hold' recommendation on Anglo American even though some of the miner's first quarter production figures were below its expectations.
Thu, 24 Apr, 2014
Shore Capital has retained its 'buy' stance on Barclays but has highlighted readacross from reports that German banking peer Deutsche Bank is under pressure from investors to raise more capital.
Thu, 24 Apr, 2014
Hargreaves Lansdown said the City was advising investors to hang onto their shares in Unilever as the consumer goods group faced currency headwinds and below-inflation wage growth.
Thu, 24 Apr, 2014
AMEC: UBS ups target price from 1145p to 1200p maintaining a neutral rating.
Thu, 24 Apr, 2014
Associated British Foods (ABF), one of the few remaining conglomerates on the FTSE 100, yesterday released a strong first half trading update, including a six per cent increase in pre-tax profits. That result was slightly ahead of market expectations. Together with the announcement that the company's Primark unit is to enter the US retail space it sent the stock sharply higher. However, it should be pointed out that introducing a UK retail format in the US has proven the graveyard of many a British company, with the most recent victim having been Tesco.
Wed, 23 Apr, 2014
Thursday will be another big day in capital markets in London. In particular, traders will be braced for the latest first quarter earnings figures out from drugs giant AstraZeneca.
Wed, 23 Apr, 2014
A round-up of the biggest director deals today so far.
Wed, 23 Apr, 2014
Electricity stocks were the worst performers in London on Wednesday with Drax falling sharply after the government changed the terms of a key subsidy for conversion from coal to biomass.
Wed, 23 Apr, 2014
Panmure Gordon has upgraded its rating for Associated British Foods from 'hold' to 'buy' after the company announced its intention to expand its fast-growing Primark brand into the US towards the end of next year.
Wed, 23 Apr, 2014
Spirent Communications's first-quarter results impressed the market on Wednesday with revenues and profits ahead of expectations, though Investec said that figures are 'not as good as they appear on the surface'.
Wed, 23 Apr, 2014
The potential value of AstraZeneca's (AZN) drug pipeline is still under-appreciated by the market, with or without a bid from US pharmaceutical peer Pfizer (PFE), according to Citigroup.
Wed, 23 Apr, 2014
Wolseley's share price was making gains on Wednesday after Credit Suisse upgraded the stock from 'neutral' to 'outperform', saying that it foresees substantial capital returns at the plumbing and building materials group.
rss